Waltenberger Johannes
Department of Cardiology, University of Maastricht, Cardiovascular Research Institute of Maastricht CARIM, P. Debyelaan 25, P.O. Box 5800, NL-6202 AZ Maastricht, The Netherlands.
Cardiovasc Res. 2005 Feb 15;65(3):574-80. doi: 10.1016/j.cardiores.2004.11.001.
Growth factors are important molecules mediating both the development as well as adaptive and pathological changes within the cardiovascular system. Growth factors therefore mediate both beneficial and nonbeneficial effects. The beneficial actions include the improvement of endothelial function, stimulation of vascular repair, the formation of new capillaries (angiogenesis), and the growth of collateral arteries (arteriogenesis). These actions represent the conceptual basis for the therapeutic use of growth factors, based on the idea to therapeutically induce or accelerate a given beneficial process. The beneficial effects of growth factors have to be separated from effects where growth factors act as mediators of pathological processes such as atherogenesis and plaque destabilization. This review article focuses on the physiological and beneficial effects of growth factors in the vessel wall and describes and explains the dysfunction of these effects under certain conditions now referred to as "growth factor signal transduction defects".
生长因子是介导心血管系统发育以及适应性和病理性变化的重要分子。因此,生长因子介导有益和非有益作用。有益作用包括改善内皮功能、刺激血管修复、形成新的毛细血管(血管生成)以及侧支动脉生长(动脉生成)。这些作用代表了生长因子治疗应用的概念基础,其理念是通过治疗诱导或加速特定的有益过程。生长因子的有益作用必须与作为病理过程(如动脉粥样硬化和斑块不稳定)介导因子的作用区分开来。这篇综述文章重点关注生长因子在血管壁中的生理和有益作用,并描述和解释在某些条件下现在称为“生长因子信号转导缺陷”的这些作用的功能障碍。